Altered gene expression of histone deacetylases in mood disorder patients

Journal of Psychiatric Research

Volumn 44, Issue 5, 2010, Pages 263-270

  Hobara, Teruyuki ^a   Uchida, Shusaku ^a   Otsuki, Koji ^a   Matsubara, Toshio ^a   Funato, Hiromasa ^a   Matsuo, Koji ^a   Suetsugi, Masatomo ^a   Watanabe, Yoshifumi ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Bipolar depression; Chromatin regulation; Gene expression; Histone deacetylase; Leukocyte; Major depression

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLOMIPRAMINE; COMPLEMENTARY DNA; HISTONE DEACETYLASE; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 6; HISTONE DEACETYLASE 8; HYDROCORTISONE; LITHIUM CHLORIDE; MESSENGER RNA; MOOD STABILIZER; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG ACTIVITY; FEMALE; FORCED SWIMMING TEST; GENE EXPRESSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; LEUKOCYTE; MAJOR DEPRESSION; MALE; MOOD DISORDER; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; RNA EXTRACTION; RNA ISOLATION;

EID: 77649192193     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2009.08.015     Document Type: Article

References (55)

1. Abel T., and Zukin R.S. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Current Opinion in Pharmacology 8 (2008) 57-64
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Press, Washington, DC
3. Anitha A., Nakamura K., Yamada K., Iwayama Y., Toyota T., Takei N., et al. Gene and expression analyses reveal enhanced expression of pericentrin 2 (PCNT2) in bipolar disorder. Biological Psychiatry 63 (2008) 678-685
4. Ballas N., Battaglioli E., Atouf F., Andres M.E., Chenoweth J., Anderson M.E., et al. Regulation of neuronal traits by a novel transcriptional complex. Neuron 31 (2001) 353-365
5. Berton O., and Nestler E.J. New approaches to antidepressant drug discovery: beyond monoamines. Nature Reviews 7 (2006) 137-151
6. Bolger T.A., and Yao T.P. Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. The Journal of Neuroscience 25 (2005) 9544-9553
7. Carlezon Jr. W.A., Duman R.S., and Nestler E.J. The many faces of CREB. Trends in Neurosciences 28 (2005) 436-445
8. Clark J.A., Flick R.B., Pai L.Y., Szalayova I., Key S., Conley R.K., et al. Glucocorticoid modulation of tryptophan hydroxylase-2 protein in raphe nuclei and 5-hydroxytryptophan concentrations in frontal cortex of C57/Bl6 mice. Molecular Psychiatry 13 (2008) 498-506
9. Colvis C.M., Pollock J.D., Goodman R.H., Impey S., Dunn J., Mandel G., et al. Epigenetic mechanisms and gene networks in the nervous system. The Journal of Neuroscience 25 (2005) 10379-10389
10. Coyle J.T., and Duman R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38 (2003) 157-160
11. Cryan J.F., Markou A., and Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences 23 (2002) 238-245
12. de Kloet E.R., Joels M., and Holsboer F. Stress and the brain: from adaptation to disease. Nature Reviews 6 (2005) 463-475
13. Dehpour A.R., Sadr S.S., Nouroddini M., Shadan F., Nourozi A., Farahani M., et al. Comparison of simultaneous administration of lithium with L-NAME or L-arginine on morphine withdrawal syndrome in mice. Human Psychopharmacology 15 (2000) 87-93
14. Dulawa S.C., Holick K.A., Gundersen B., and Hen R. Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29 (2004) 1321-1330
15. Eilat E., Mendlovic S., Doron A., Zakuth V., and Spirer Z. Increased apoptosis in patients with major depression: A preliminary study. Journal of Immunology 163 (1999) 533-534
16. Etchegaray J.P., Lee C., Wade P.A., and Reppert S.M. Rhythmic histone acetylation underlies transcription in the mammalian circadian clock. Nature 421 (2003) 177-182
17. Gottlicher M., Minucci S., Zhu P., Kramer O.H., Schimpf A., Giavara S., et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. The EMBO Journal 20 (2001) 6969-6978
18. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 389 (1997) 349-352
19. Guan Z., Giustetto M., Lomvardas S., Kim J.H., Miniaci M.C., Schwartz J.H., et al. Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure. Cell 111 (2002) 483-493
20. Heuser I., Yassouridis A., and Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. Journal of Psychiatric Research 28 (1994) 341-356
21. Heuser I.J., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Dettling M., et al. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. The American Journal of Psychiatry 153 (1996) 93-99
22. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (2000) 477-501
23. Holsboer F., Lauer C.J., Schreiber W., and Krieg J.C. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62 (1995) 340-347
24. Hsieh J., and Gage F.H. Chromatin remodeling in neural development and plasticity. Current Opinion in Cell Biology 17 (2005) 664-671
25. Iga J., Ueno S., Yamauchi K., Numata S., Kinouchi S., Tayoshi-Shibuya S., et al. Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (2007) 628-632
26. Ito K., Barnes P.J., and Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Molecular and Cellular Biology 20 (2000) 6891-6903
27. Ivanova S.A., Semke V.Y., Vetlugina T.P., Rakitina N.M., Kudyakova T.A., and Simutkin G.G. Signs of apoptosis of immunocompetent cells in patients with depression. Neuroscience and Behavioral Physiology 37 (2007) 527-530
28. Kakiuchi C., Iwamoto K., Ishiwata M., Bundo M., Kasahara T., Kusumi I., et al. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nature Genetics 35 (2003) 171-175
29. O'Donnell K.C., and Gould T.D. The behavioral actions of lithium in rodent models: leads to develop novel therapeutics. Neuroscience and Biobehavioral Reviews 31 (2007) 932-962
30. Korzus E., Rosenfeld M.G., and Mayford M. CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 42 (2004) 961-972
31. Kumar A., Choi K.H., Renthal W., Tsankova N.M., Theobald D.E., Truong H.T., et al. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48 (2005) 303-314
32. Laifenfeld D., Karry R., Klein E., and Ben-Shachar D. Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study. Biological Psychiatry 57 (2005) 716-725
33. Law J.W., Lee A.Y., Sun M., Nikonenko A.G., Chung S.K., Dityatev A., et al. Decreased anxiety, altered place learning, and increased CA1 basal excitatory synaptic transmission in mice with conditional ablation of the neural cell adhesion molecule L1. The Journal of Neuroscience 23 (2003) 10419-10432
34. Levenson J.M., and Sweatt J.D. Epigenetic mechanisms in memory formation. Nature Reviews 6 (2005) 108-118
35. Manji H.K., Bebchuk J.M., Moore G.J., Glitz D., Hasanat K.A., and Chen G. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. The Journal of Clinical Psychiatry 60 Suppl. 2 (1999) 27-39 discussion 40-1, 113-6
36. Matsubara T., Funato H., Kobayashi A., Nobumoto M., and Watanabe Y. Reduced glucocorticoid receptor alpha expression in mood disorder patients and first-degree relatives. Biological Psychiatry 59 (2006) 689-695
37. Miller C.L., Llenos I.C., Cwik M., Walkup J., and Weis S. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder. Neurochemistry International 52 (2008) 1297-1303
38. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
39. Newton S.S., and Duman R.S. Chromatin remodeling: a novel mechanism of psychotropic drug action. Molecular Pharmacology 70 (2006) 440-443
40. Otsuki K., Uchida S., Watanuki T., Wakabayashi Y., Fujimoto M., Matsubara T., et al. Altered expression of neurotrophic factors in patients with major depression. Journal of Psychiatric Research 42 (2008) 1145-1153
41. Otto S.J., McCorkle S.R., Hover J., Conaco C., Han J.J., Impey S., et al. A new binding motif for the transcriptional repressor REST uncovers large gene networks devoted to neuronal functions. The Journal of Neuroscience 27 (2007) 6729-6739
42. Pandey S.C., Ugale R., Zhang H., Tang L., and Prakash A. Brain chromatin remodeling: a novel mechanism of alcoholism. The Journal of Neuroscience 28 (2008) 3729-3737
43. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., and Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. The Journal of Biological Chemistry 276 (2001) 36734-36741
44. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
45. Riccardi C., Bruscoli S., and Migliorati G. Molecular mechanisms of immunomodulatory activity of glucocorticoids. Pharmacological Research 45 (2002) 361-368
46. Schroeder F.A., Lin C.L., Crusio W.E., and Akbarian S. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biological Psychiatry 62 (2007) 55-64
47. Shabbeer S., Kortenhorst M.S., Kachhap S., Galloway N., Rodriguez R., and Carducci M.A. Multiple molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo. Prostate 67 (2007) 1099-1110
48. Tsankova N., Renthal W., Kumar A., and Nestler E.J. Epigenetic regulation in psychiatric disorders. Nature Reviews 8 (2007) 355-367
49. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., and Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nature Neuroscience 9 (2006) 519-525
50. Uchida S., Nishida A., Hara K., Kamemoto T., Suetsugi M., Fujimoto M., et al. Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. The European Journal of Neuroscience 27 (2008) 2250-2261
51. Villar-Garea A., and Esteller M. Histone deacetylase inhibitors: understanding a new wave of anticancer agents. International Journal of Cancer 112 (2004) 171-178
52. Wakabayashi Y., Uchida S., Funato H., Matsubara T., Watanuki T., Otsuki K., et al. State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (2008) 1199-1205
53. Webster M.J., Knable M.B., O'Grady J., Orthmann J., and Weickert C.S. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Molecular Psychiatry 7 (2002) 985-994 [p. 24]
54. Yamada K., Nakamura K., Minabe Y., Iwayama-Shigeno Y., Takao H., Toyota T., et al. Association analysis of FEZ1 variants with schizophrenia in Japanese cohorts. Biological Psychiatry 56 (2004) 683-690
55. Zhang X., Gainetdinov R.R., Beaulieu J.M., Sotnikova T.D., Burch L.H., Williams R.B., et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45 (2005) 11-16